Evaxion Biotech AS
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $37 | $122 | $122 | $3,026 |
Gross Profit | 37 | 122 | 3,026 | |
EBITDA | -4,785 | -1,375 | -1,647 | |
EBIT | -5,697 | -1,736 | ||
Net Income | -4,831 | -1,580 | -3,629 | -1,941 |
Net Change In Cash | 37 | 122 | 122 | 3,026 |
Cash | 14,746 | 17,843 | 5,052 | 4,576 |
Basic Shares | 4,831 | 1,105 | 70,130 | 1,381 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $3,344 | $73 | $0 | $0 |
Gross Profit | 3,344 | 72 | -571 | -343 |
EBITDA | -9,769 | -21,403 | -22,584 | -24,168 |
EBIT | -10,376 | -22,018 | -23,155 | -24,511 |
Net Income | -10,567 | -22,125 | -23,169 | -24,532 |
Net Change In Cash | 3,344 | 73 | 0 | 0 |
Free Cash Flow | -12,940 | -17,778 | -26,066 | -23,293 |
Cash | 5,052 | 5,583 | 13,184 | 32,166 |
Basic Shares | 1,072 | 683 | 590 | 487 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$1 |
2025-03-31 | -$3.14 |
2024-12-31 | -$0.07 |
2024-09-30 | -$0.04 |
